Effect of donor/recipient sex on relapse among patients who underwent transplantation for CML, AML, and ALL, controlling for GVHD
. | Adjusted hazard ratio* . | 95% CI . | P . |
|---|---|---|---|
| CML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.78 | 0.53-1.15 | .21 |
| AML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.83 | 0.60-1.16 | .27 |
| ALL | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.75 | 0.54-1.04 | .09 |
. | Adjusted hazard ratio* . | 95% CI . | P . |
|---|---|---|---|
| CML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.78 | 0.53-1.15 | .21 |
| AML | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.83 | 0.60-1.16 | .27 |
| ALL | |||
| Other sex combinations | 1 | NA | NA |
| Female/male | 0.75 | 0.54-1.04 | .09 |
NA indicates not applicable.
Adjusted for patient and donor age, GVHD prophylaxis, disease status, conditioning regimen, and patient/donor CMV serostatus.